sce presentation, page-92

So I'm a bit of a rookie when it comes to biotechs. I really only hold them short term for a technical trade. But as for investing in them, I can never see the reward outbalancing the risk.

BUT...

I do like that 60 odd companies have approached ADO, and that ADO could gain a $600M market share in the sector.

My question is, how fast will things move along once ADO signs with a pharmaceutical brand? Would the quality of the brand matter much, or is just making that new step enough in its own right? Furthermore, realistically how close is ADO to this milestone. 3 months? or 12 months?

Thanks for helping out. If there was one biotech that I see as worthy of investing in, ADO is it in my eyes.